Rolinsatamab ELISA Kit
Product Specifications
Background
Rituximab is a genetically engineered chimeric murine/human monoclonal antibody specific to CD20. CD20 is an approximately 35 KDa transmembrane phosphoprotein involved in the activation, proliferation, and differentiation of B-lymphocytes. It is absent in terminally differentiated plasma cells. The Fab domain of Rituximab binds to the CD20 antigen on B-lymphocytes and the Fc domain recruits immune effector functions to induce apoptosis in B cells and is used in the treatment of leukemia s and lymphomas, some autoimmune disorders, and organ transplant.
Product Name Alternative
PR-1594804, h16f, ABBV-176, DC-1630993, h16f, Rolinsatamab talirine, CAS: 2095467-30-2
Detection Method
Colorimetric
Assay Type
Quantitative
Sample Type
Plasma, Serum
Detection Range
0.31-5 μg/mL
Recovery
80-120 %
Sensitivity
0.156 μg/ml
Shipping Conditions
2-8 °C
Storage Conditions
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS9369293-01 48 Well
Horse Double C2-Like Domain-Containing Protein Beta (DOC2B) ELISA Kit
Ask
View Details